These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 36843367)
1. Nanodiamond Mediated Molecular Targeting in Pancreatic Ductal Adenocarcinoma: Disrupting the Tumor-stromal Cross-talk, Next Hope on the Horizon? Singh M; Pal P; Dutta RS; Marbaniang D; Ray S; Mazumder B Curr Cancer Drug Targets; 2023; 23(8):620-633. PubMed ID: 36843367 [TBL] [Abstract][Full Text] [Related]
2. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts. Liu H; Shi Y; Qian F Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881 [TBL] [Abstract][Full Text] [Related]
3. CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer. Pereira BA; Vennin C; Papanicolaou M; Chambers CR; Herrmann D; Morton JP; Cox TR; Timpson P Trends Cancer; 2019 Nov; 5(11):724-741. PubMed ID: 31735290 [TBL] [Abstract][Full Text] [Related]
4. The Paradoxical Web of Pancreatic Cancer Tumor Microenvironment. Lafaro KJ; Melstrom LG Am J Pathol; 2019 Jan; 189(1):44-57. PubMed ID: 30558722 [TBL] [Abstract][Full Text] [Related]
5. Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma. Zhao X; Fan W; Xu Z; Chen H; He Y; Yang G; Yang G; Hu H; Tang S; Wang P; Zhang Z; Xu P; Yu M Oncotarget; 2016 Dec; 7(49):81110-81122. PubMed ID: 27835602 [TBL] [Abstract][Full Text] [Related]
6. Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours. Huang HC; Sung YC; Li CP; Wan D; Chao PH; Tseng YT; Liao BW; Cheng HT; Hsu FF; Huang CC; Chen YT; Liao YH; Hsieh HT; Shih YC; Liu IJ; Wu HC; Lu TT; Wang J; Chen Y Gut; 2022 Sep; 71(9):1843-1855. PubMed ID: 34921062 [TBL] [Abstract][Full Text] [Related]
7. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer. Nagathihalli NS; Castellanos JA; Shi C; Beesetty Y; Reyzer ML; Caprioli R; Chen X; Walsh AJ; Skala MC; Moses HL; Merchant NB Gastroenterology; 2015 Dec; 149(7):1932-1943.e9. PubMed ID: 26255562 [TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment. Tarannum M; Vivero-Escoto JL Adv Drug Deliv Rev; 2022 Aug; 187():114357. PubMed ID: 35605679 [TBL] [Abstract][Full Text] [Related]
9. Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy. Zhang YF; Jiang SH; Hu LP; Huang PQ; Wang X; Li J; Zhang XL; Nie HZ; Zhang ZG Chin Clin Oncol; 2019 Apr; 8(2):18. PubMed ID: 31070038 [TBL] [Abstract][Full Text] [Related]